Population Studies: Inclusion of non-AD cohorts

Support the inclusion of measures of AD-related phenotypes and environmental exposures in non-AD cohorts to enable new discovery research and to accelerate cross-validation of discoveries made in AD cohorts.

2030 PAR-15-349: Health Disparities and Alzheimer's Disease (R01) PAR-19-269: Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) PAR-21-157: The Midlife in the United States Study- Cognitive and Neurocognitive Precursors of AD/ADRD RFA-AG-21-008: National Longitudinal Study of Adolescent to Adult Health (Add Health) – Wave 6 NOT-AG-22-022: Administrative Supplements to Support Research Infrastructure on Exposome Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) RFA-AG-24-011: Research Coordinating Center on the Exposome and AD/ADRD: Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities RFA-AG-24-022: Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) PREPARE Challenge: Pioneering Research for Early Prediction of Alzheimer's Disease & Related Dementias RFA-AG-25-005 Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trail Not Allowed) RFA-AG-23-020: Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimer’s Disease (AD) and AD-Related Dementias RFA-AG-24-027: Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) 1.F In Progress Support the inclusion of measures of AD-related phenotypes and environmental exposures in non-AD cohorts... DN 2018 AD Summit: 5C Workshop: Gaps and Opportunities for Real-World Data: Stakeholder Workshop Workshop: The Landscape of Early (Neuro)Psychological Changes in AD/ADRD Project Webinar Series Highlight: Education and gender inequality may explain why India’s women have worse late-life cognition Highlight: Excess belly fat in midlife may be associated with early markers of Alzheimer’s Highlight: Loneliness linked to dementia risk in large-scale analysis Highlight: World Trade Center attack responders may have higher risk of early-onset dementia Workshop: The Future of Population-Based Studies in Alzheimer’s Disease and Related Dementia Research: Setting Future Scientific Priorities Population Studies and Precision Medicine Projects funded under RFA-AG-21-008 Supplements funded under NOT-AG-22-022 in FY22 Integrative Pathways to Cognitive, Affective, and Brain Health P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer's Disease continuum in South Asians in India Multiethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC)

  • Provide supplemental funding to at least 6 clinical research studies on well-phenotyped, diverse, midlife cohorts, to explore the impact of environmental exposures on the pathogenesis of AD and AD-related dementias. These efforts should include support for the development of novel, open source computational methods for data mining and data integration.

Summary of Key Accomplishments

NIA has supported and continues to support the inclusion of population studies not originally designed to study AD in collecting and analyzing cognitive and other data that may support our understanding of the protective and risk factors of dementia. NIA supported supplemental funding to existing longitudinal research studies to measure biomarkers and identify possible risk factors for age-related diseases, including dementia. NIA issued a funding opportunity to add new cognitive measures to the Midlife in the U.S. (MIDUS) study to leverage this non-AD cohort to understand the risk factors that lead to dementia. The National Longitudinal Study of Adolescent to Adult Health (Add Health) gathers demographic, and other data along with information about respondents’ neighborhoods and communities and with a new award will soon gather cognitive function data from individuals first interviewed as adolescents in 1994 who are now approaching midlife. High School and Beyond prospectively follows a cohort of 1980 high school sophomores and seniors who are now reaching age 60, with additional studies examining the impact of pollution on cognitive function. NIA has supported research on brain aging and AD/ADRD in the Framingham Heart Study (FHS). In 2020, NIA established the FHS Brain Aging Program (FHS-BAP) to continue tracking and evaluating FHS participants for dementia and to invigorate the study’s brain donation program and brain bank. The FHS-BAP will also establish a platform to promote data sharing and conduct three interrelated projects focused on understanding how genetic and environmental factors interact and lead to different risk and resilience profiles.

Additionally, an NIA supported multidisciplinary research team is leveraging 14 years of research on the Tsimane people to understand how environmental factors associated with pre-industrial lifestyle influence brain aging and risk and resilience to AD.

The key accomplishments summary is current as of July 2022.